| | | | | | | |
 | REGENERON PHARMACEUTICALS, INC. | 0.07% | -0.92% | 5.30% | 9.60% | 73.28% | 81 086 |
| VERTEX PHARMACEUTICALS | 1.24% | 2.51% | 4.81% | 20.94% | 46.92% | 77 811 |
 | WUXI APPTEC CO., LTD. | 8.46% | 2.50% | -0.91% | -24.07% | 46.28% | 33 978 |
 | GENMAB A/S | 0.00% | 1.72% | -13.40% | 5.20% | 100.08% | 24 061 |
| BEIGENE, LTD. | 1.26% | -2.36% | 2.69% | 25.74% | 79.25% | 23 576 |
 | ARGENX SE | -0.42% | 0.94% | -4.48% | 17.40% | 191.33% | 19 985 |
| SAREPTA THERAPEUTICS, INC. | -0.16% | -9.48% | 1.23% | 62.00% | 50.75% | 11 541 |
| NEUROCRINE BIOSCIENCES, INC. | -0.79% | 1.01% | -19.26% | 2.42% | 19.59% | 9 315 |
| LEGEND BIOTECH CORPORATION | -2.73% | -4.74% | -9.92% | 17.63% | --.--% | 7 528 |
| ASCENDIS PHARMA A/S | -0.80% | -0.40% | -10.82% | -2.38% | 6.28% | 6 122 |
| EXELIXIS, INC. | 1.31% | 6.30% | 15.77% | -12.61% | 22.57% | 6 018 |
| KARUNA THERAPEUTICS, INC. | -11.60% | -14.18% | -17.90% | 38.99% | 119.08% | 5 570 |
 | REMEGEN CO., LTD. | -3.15% | 5.98% | -12.52% | 0.30% | --.--% | 5 123 |
| AKESO, INC. | -4.04% | 9.74% | -0.70% | 177.63% | --.--% | 4 770 |
| HALOZYME THERAPEUTICS, INC. | -0.66% | -17.64% | -39.21% | -7.02% | 122.16% | 4 682 |
| | | | | | | |
| | Moyenne | -0.80% | -1.27% | -6.62% | 22.12% | 73.13% | |
| | Moyenne pondérée par Capi. | 0.88% | 0.08% | -0.43% | 13.96% | 70.60% | |
Google
Twitter
Facebook
Apple
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Italiano
Nederlands (Nederland)
Nederlands (België)
bourse
Rapport
